Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No.	Source	Source type	Diagnosis	Medical sector	Year of application	Therapy	Country	Age of the recipient
2201	Apheresis	Allogeneic	Hurler Syndrome	Hematology	2021	Standard Therapy	Poland	2
2202	Apheresis	Allogeneic	Immunodeficiency	Hematology	2021	Standard Therapy	Poland	12
2203	Apheresis	Allogeneic	Leukemia	Hematology	2021	Standard Therapy	Poland	63
2204	Apheresis	Allogeneic	Lymphoma	Hematology	2021	Standard Therapy	Poland	58
2205	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	66
2206	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	57
2207	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	66
2208	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	57
2209	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	63
2210	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	56
2211	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2021	Standard Therapy	Germany	65
2212	Apheresis	Allogeneic	Metachromatic Leukodystrophy	Hematology	2021	Standard Therapy	Poland	60
2213	Apheresis	Autologous	Morbus Hodgkin	Hematology	2021	Standard Therapy	Germany	36
2214	Apheresis	Autologous	Morbus Hodgkin	Hematology	2021	Standard Therapy	Germany	50
2215	Apheresis	Autologous	Morbus Hodgkin	Hematology	2021	Standard Therapy	Germany	21
2216	Apheresis	Allogeneic	Mucopolysaccharidosis	Hematology	2021	Standard Therapy	Poland	2
2217	Apheresis	Allogeneic	Multiple Myeloma	Hematology	2021	Standard Therapy	Poland	44
2218	Apheresis	Allogeneic	Multiple Myeloma	Hematology	2021	Standard Therapy	Poland	60
2219	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	70
2220	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	71
2221	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	53
2222	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	51
2223	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	61
2224	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	65
2225	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	62
2226	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	57
2227	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	66
2228	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	50
2229	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	65
2230	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	50
2231	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	47
2232	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	43
2233	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	66
2234	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	56
2235	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	65
2236	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	51
2237	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	61
2238	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	62
2239	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	68
2240	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	70
2241	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	70
2242	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	38
2243	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	61
2244	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	63
2245	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	71
2246	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	52
2247	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	63
2248	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	57
2249	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	68
2250	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	61
2251	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	58
2252	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	57
2253	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	60
2254	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	58
2255	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	67
2256	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	62
2257	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	42
2258	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	61
2259	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	67
2260	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	57
2261	Apheresis	Autologous	Multiple Myeloma	Hematology	2021	Standard Therapy	Germany	68
2262	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	68
2263	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	41
2264	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	60
2265	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	8
2266	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	61
2267	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	62
2268	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	68
2269	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	65
2270	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	56
2271	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	62
2272	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	57
2273	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	47
2274	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	65
2275	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	29
2276	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	66
2277	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	70
2278	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	70
2279	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	59
2280	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	50
2281	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	59
2282	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	28
2283	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	68
2284	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	65
2285	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	54
2286	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	66
2287	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	52
2288	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	70
2289	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	75
2290	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	72
2291	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	62
2292	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	40
2293	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	65
2294	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	67
2295	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	72
2296	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	64
2297	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	64
2298	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	53
2299	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	53
2300	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2021	Standard Therapy	Poland	73

Previous

Page 23 of 72 1 21 22 23 24 25 72

Next